National guideline for the management of genital herpes

Sexually Transmitted Infections

Volumn 75, Issue SUPPL. 1, 1999, Pages

  Barton, Simon ^a   Brown, David ^a   Cowan, Frances M ^a   Jeffries, Don ^a   Kinghorn, George ^a   Munday, Patricia E ^a   Patel, Raj ^a   Scoular, Anne ^a   Smith, J Richard ^a   Timmins, Derek ^a   Woolley, Paul ^a   Whitaker, Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FAMCICLOVIR; VALACICLOVIR;

AUTONOMIC NEUROPATHY; CLINICAL FEATURE; CLINICAL PROTOCOL; ENZYME IMMUNOASSAY; FEVER; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; MYALGIA; PATIENT COUNSELING; PLACENTAL TRANSFER; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; TREATMENT PLANNING; URINE RETENTION; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

2-AMINOPURINE; ACYCLOVIR; ANTIVIRAL AGENTS; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VALINE;

EID: 2942620938     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994;121:847-54.
2. Benedetti J, Zeh J, Selke S, et al. Frequency and reactivation of nongenital recurrences among patients with genital herpes simplex virus. Am J Med 1995;98:237-42.
3. Cone RW, Swenson PD, Hobson AC, et al. Herpes simplex virus detection from genital lesions; a comparative study using antigen detection (HerpChek) and culture. J Clin Microbiol 1993;31:1774-6.
4. Kudesia G, Van Hegan A, Wake S, et al. Comparison of cell culture with an amplified enzyme immunoassay for diagnosing genital herpes simplex infection. J Clin Path 1991;44:778-80.
5. Corey L, Benedetti J, Critchlow C, et al. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy. J Antimicrob Chemother 1983;12(Suppl B):79-88.
6. Fife KH, Barbarash RA, Rudolph T, et al. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis 1997;24:481-6.
7. Corey L, Mindel A, Fife KH, et al. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir. Sex Transm Dis 1985;12:215-18.
8. Nilsen AE, Aasen T, Halos AM, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet 1982;ii:571-3.
9. Spruance SL, Tyring SK, DeGregoria B, et al, and the Valaciclovir study group. A large-scale, placebo controlled, dose ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 1996;156:1729-35.
10. Sacks SL, Aoki FY, Diaz-Mitoma F, et al, for the Canadian Famciclovir Study. Patient-initiated, twice daily oral famciclovir for early recurrent genital herpes: a randomized, double-blind multicenter trial. JAMA 1996;276:44-9.
11. Patel R, Bodsworth NJ, Wooley P, et al, and the International Valaciclovir HSV Study Group. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. Genitourin Med 1997;73:105-9.
12. Mertz GJ, Jones CC, Mills J, et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA 1988;260:201-6.
13. Mertz GJ, Loveless MO, Levin MJ, et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Arch Intern Med 1997;157:343-9.
14. Wald A, Zeh J, Barnum G, at al. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124:8-15.
15. Koelle DM, Benedetti J, Langenberg A, et al. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992;116:433-7.
16. Mertz GJ, Remedetto J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
17. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337: 509-15.
18. Mertz, GJ, Schmidt O, Jourdan JL, et al. Frequcncy of acquisition of first episode gential infection with herpes simplex virus infection from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985; 12:33-9.
19. Langenberg A, Benedetti J, Jenkins J, et al. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med 1989;110:882-7.
20. Scou LL, Sanchez PJ, Jackson GL, et al. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996;87:69-73.
21. Prober CG, Hensleigh PA, Boucher FD, et al. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N Engl J Med 1988;318:887-91.
22. Prober CG, Sullender WM, Yasukawa LL, et al. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes. N Engl J Med 1987;316:240-4.
23. Balfour HH Jr, Benson C, Braun J, et al. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr 1994;7:254-60.
24. Lalezari J, Schacker T, Feinberg J, et al. A randomised double blind placebo controlled trial of cidofovir gel for the treatment of acydovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS. J Infect Dis 1997;176:892-8.